Skip to main content
Fig. 5 | Cancer Nanotechnology

Fig. 5

From: Doxorubicin-loaded liposomes surface engineered with the matrix metalloproteinase-2 cleavable polyethylene glycol conjugate for cancer therapy

Fig. 5

MMP-2 mRNA expression in the NIH-3T3, C26, 4T1, and B16F10 cells (A). Gelatinase zymogram (B) and densitometry analysis (C) of MMP-2 secretion in NIH-3T3, C26, 4T1, and B16F10 cells. All experiments were performed in triplicates and results are presented as the mean ± SD. Statistical significance is compared to the control group and shown as follows: *P < 0.05, **P < 0.01

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us